Global Stereotactic-guided Biopsy Instrument Market Research Report 2022

Publisher Name :
Date: 07-Jul-2022
No. of pages: 92
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Needle-based Biopsy Instruments

- Localization Wires

- Procedure Trays

- Others

Segment by Application

- Breast Biopsy

- Lung Biopsy

- Colorectal Biopsy

- Prostate Biopsy

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- C. R. Bard, Inc. (U.S.)

- Becton, Dickinson and Company (U.S.)

- Cook Group Incorporated (U.S.)

- Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

- Argon Medical Devices (U.S.)

- B. Braun Melsungen AG (Germany)

- Cardinal Health, Inc. (U.S.)

- Olympus Corporation (Japan)

- Boston Scientific Corporation (U.S.)

- FUJIFILM Holdings Corporation (Japan)

- INRAD, Inc. (U.S.)

- Medtronic plc (Ireland)

Global Stereotactic-guided Biopsy Instrument Market Research Report 2022

Table of Contents
1 Stereotactic-guided Biopsy Instrument Market Overview
1.1 Product Overview and Scope of Stereotactic-guided Biopsy Instrument
1.2 Stereotactic-guided Biopsy Instrument Segment by Type
1.2.1 Global Stereotactic-guided Biopsy Instrument Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Needle-based Biopsy Instruments
1.2.3 Localization Wires
1.2.4 Procedure Trays
1.2.5 Others
1.3 Stereotactic-guided Biopsy Instrument Segment by Application
1.3.1 Global Stereotactic-guided Biopsy Instrument Sales Comparison by Application: (2022-2028)
1.3.2 Breast Biopsy
1.3.3 Lung Biopsy
1.3.4 Colorectal Biopsy
1.3.5 Prostate Biopsy
1.3.6 Others
1.4 Global Stereotactic-guided Biopsy Instrument Market Size Estimates and Forecasts
1.4.1 Global Stereotactic-guided Biopsy Instrument Revenue 2017-2028
1.4.2 Global Stereotactic-guided Biopsy Instrument Sales 2017-2028
1.4.3 Stereotactic-guided Biopsy Instrument Market Size by Region: 2017 Versus 2021 Versus 2028
2 Stereotactic-guided Biopsy Instrument Market Competition by Manufacturers
2.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturers (2017-2022)
2.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Stereotactic-guided Biopsy Instrument Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Stereotactic-guided Biopsy Instrument Manufacturing Sites, Area Served, Product Type
2.5 Stereotactic-guided Biopsy Instrument Market Competitive Situation and Trends
2.5.1 Stereotactic-guided Biopsy Instrument Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Stereotactic-guided Biopsy Instrument Players Market Share by Revenue
2.5.3 Global Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Stereotactic-guided Biopsy Instrument Retrospective Market Scenario by Region
3.1 Global Stereotactic-guided Biopsy Instrument Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Stereotactic-guided Biopsy Instrument Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.3.1 North America Stereotactic-guided Biopsy Instrument Sales by Country
3.3.2 North America Stereotactic-guided Biopsy Instrument Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.4.1 Europe Stereotactic-guided Biopsy Instrument Sales by Country
3.4.2 Europe Stereotactic-guided Biopsy Instrument Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Stereotactic-guided Biopsy Instrument Market Facts & Figures by Region
3.5.1 Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region
3.5.2 Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.6.1 Latin America Stereotactic-guided Biopsy Instrument Sales by Country
3.6.2 Latin America Stereotactic-guided Biopsy Instrument Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.7.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country
3.7.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Stereotactic-guided Biopsy Instrument Historic Market Analysis by Type
4.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)
4.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2017-2022)
4.3 Global Stereotactic-guided Biopsy Instrument Price by Type (2017-2022)
5 Global Stereotactic-guided Biopsy Instrument Historic Market Analysis by Application
5.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)
5.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2017-2022)
5.3 Global Stereotactic-guided Biopsy Instrument Price by Application (2017-2022)
6 Key Companies Profiled
6.1 C. R. Bard, Inc. (U.S.)
6.1.1 C. R. Bard, Inc. (U.S.) Corporation Information
6.1.2 C. R. Bard, Inc. (U.S.) Description and Business Overview
6.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.1.4 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio
6.1.5 C. R. Bard, Inc. (U.S.) Recent Developments/Updates
6.2 Becton, Dickinson and Company (U.S.)
6.2.1 Becton, Dickinson and Company (U.S.) Corporation Information
6.2.2 Becton, Dickinson and Company (U.S.) Description and Business Overview
6.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio
6.2.5 Becton, Dickinson and Company (U.S.) Recent Developments/Updates
6.3 Cook Group Incorporated (U.S.)
6.3.1 Cook Group Incorporated (U.S.) Corporation Information
6.3.2 Cook Group Incorporated (U.S.) Description and Business Overview
6.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio
6.3.5 Cook Group Incorporated (U.S.) Recent Developments/Updates
6.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
6.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
6.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Business Overview
6.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product Portfolio
6.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments/Updates
6.5 Argon Medical Devices (U.S.)
6.5.1 Argon Medical Devices (U.S.) Corporation Information
6.5.2 Argon Medical Devices (U.S.) Description and Business Overview
6.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio
6.5.5 Argon Medical Devices (U.S.) Recent Developments/Updates
6.6 B. Braun Melsungen AG (Germany)
6.6.1 B. Braun Melsungen AG (Germany) Corporation Information
6.6.2 B. Braun Melsungen AG (Germany) Description and Business Overview
6.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.6.4 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product Portfolio
6.6.5 B. Braun Melsungen AG (Germany) Recent Developments/Updates
6.7 Cardinal Health, Inc. (U.S.)
6.6.1 Cardinal Health, Inc. (U.S.) Corporation Information
6.6.2 Cardinal Health, Inc. (U.S.) Description and Business Overview
6.6.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio
6.7.5 Cardinal Health, Inc. (U.S.) Recent Developments/Updates
6.8 Olympus Corporation (Japan)
6.8.1 Olympus Corporation (Japan) Corporation Information
6.8.2 Olympus Corporation (Japan) Description and Business Overview
6.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Portfolio
6.8.5 Olympus Corporation (Japan) Recent Developments/Updates
6.9 Boston Scientific Corporation (U.S.)
6.9.1 Boston Scientific Corporation (U.S.) Corporation Information
6.9.2 Boston Scientific Corporation (U.S.) Description and Business Overview
6.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio
6.9.5 Boston Scientific Corporation (U.S.) Recent Developments/Updates
6.10 FUJIFILM Holdings Corporation (Japan)
6.10.1 FUJIFILM Holdings Corporation (Japan) Corporation Information
6.10.2 FUJIFILM Holdings Corporation (Japan) Description and Business Overview
6.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.10.4 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Portfolio
6.10.5 FUJIFILM Holdings Corporation (Japan) Recent Developments/Updates
6.11 INRAD, Inc. (U.S.)
6.11.1 INRAD, Inc. (U.S.) Corporation Information
6.11.2 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Description and Business Overview
6.11.3 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.11.4 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio
6.11.5 INRAD, Inc. (U.S.) Recent Developments/Updates
6.12 Medtronic plc (Ireland)
6.12.1 Medtronic plc (Ireland) Corporation Information
6.12.2 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Description and Business Overview
6.12.3 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product Portfolio
6.12.5 Medtronic plc (Ireland) Recent Developments/Updates
7 Stereotactic-guided Biopsy Instrument Manufacturing Cost Analysis
7.1 Stereotactic-guided Biopsy Instrument Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument
7.4 Stereotactic-guided Biopsy Instrument Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Stereotactic-guided Biopsy Instrument Distributors List
8.3 Stereotactic-guided Biopsy Instrument Customers
9 Stereotactic-guided Biopsy Instrument Market Dynamics
9.1 Stereotactic-guided Biopsy Instrument Industry Trends
9.2 Stereotactic-guided Biopsy Instrument Market Drivers
9.3 Stereotactic-guided Biopsy Instrument Market Challenges
9.4 Stereotactic-guided Biopsy Instrument Market Restraints
10 Global Market Forecast
10.1 Stereotactic-guided Biopsy Instrument Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Stereotactic-guided Biopsy Instrument by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument by Type (2023-2028)
10.2 Stereotactic-guided Biopsy Instrument Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Stereotactic-guided Biopsy Instrument by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument by Application (2023-2028)
10.3 Stereotactic-guided Biopsy Instrument Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Stereotactic-guided Biopsy Instrument by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Stereotactic-guided Biopsy Instrument Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Stereotactic-guided Biopsy Instrument Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Stereotactic-guided Biopsy Instrument Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Stereotactic-guided Biopsy Instrument Market Competitive Situation by Manufacturers in 2021
Table 5. Global Stereotactic-guided Biopsy Instrument Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Stereotactic-guided Biopsy Instrument Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Stereotactic-guided Biopsy Instrument Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Stereotactic-guided Biopsy Instrument Manufacturing Sites and Area Served
Table 11. Manufacturers Stereotactic-guided Biopsy Instrument Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Stereotactic-guided Biopsy Instrument by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stereotactic-guided Biopsy Instrument as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Stereotactic-guided Biopsy Instrument Sales by Region (2017-2022) & (K Units)
Table 16. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2017-2022)
Table 17. Global Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2017-2022)
Table 19. North America Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 20. North America Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2017-2022)
Table 21. North America Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2017-2022)
Table 23. Europe Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 24. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2017-2022)
Table 25. Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2017-2022)
Table 31. Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2017-2022)
Table 33. Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2017-2022)
Table 39. Global Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)
Table 40. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)
Table 41. Global Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Stereotactic-guided Biopsy Instrument Revenue Share by Type (2017-2022)
Table 43. Global Stereotactic-guided Biopsy Instrument Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Stereotactic-guided Biopsy Instrument Sales (K Units) by Application (2017-2022)
Table 45. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)
Table 46. Global Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Stereotactic-guided Biopsy Instrument Revenue Share by Application (2017-2022)
Table 48. Global Stereotactic-guided Biopsy Instrument Price by Application (2017-2022) & (USD/Unit)
Table 49. C. R. Bard, Inc. (U.S.) Corporation Information
Table 50. C. R. Bard, Inc. (U.S.) Description and Business Overview
Table 51. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 53. C. R. Bard, Inc. (U.S.) Recent Developments/Updates
Table 54. Becton, Dickinson and Company (U.S.) Corporation Information
Table 55. Becton, Dickinson and Company (U.S.) Description and Business Overview
Table 56. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 58. Becton, Dickinson and Company (U.S.) Recent Developments/Updates
Table 59. Cook Group Incorporated (U.S.) Corporation Information
Table 60. Cook Group Incorporated (U.S.) Description and Business Overview
Table 61. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 63. Cook Group Incorporated (U.S.) Recent Developments/Updates
Table 64. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
Table 65. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Business Overview
Table 66. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product
Table 68. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments/Updates
Table 69. Argon Medical Devices (U.S.) Corporation Information
Table 70. Argon Medical Devices (U.S.) Description and Business Overview
Table 71. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 73. Argon Medical Devices (U.S.) Recent Developments/Updates
Table 74. B. Braun Melsungen AG (Germany) Corporation Information
Table 75. B. Braun Melsungen AG (Germany) Description and Business Overview
Table 76. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product
Table 78. B. Braun Melsungen AG (Germany) Recent Developments/Updates
Table 79. Cardinal Health, Inc. (U.S.) Corporation Information
Table 80. Cardinal Health, Inc. (U.S.) Description and Business Overview
Table 81. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 83. Cardinal Health, Inc. (U.S.) Recent Developments/Updates
Table 84. Olympus Corporation (Japan) Corporation Information
Table 85. Olympus Corporation (Japan) Description and Business Overview
Table 86. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product
Table 88. Olympus Corporation (Japan) Recent Developments/Updates
Table 89. Boston Scientific Corporation (U.S.) Corporation Information
Table 90. Boston Scientific Corporation (U.S.) Description and Business Overview
Table 91. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 93. Boston Scientific Corporation (U.S.) Recent Developments/Updates
Table 94. FUJIFILM Holdings Corporation (Japan) Corporation Information
Table 95. FUJIFILM Holdings Corporation (Japan) Description and Business Overview
Table 96. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product
Table 98. FUJIFILM Holdings Corporation (Japan) Recent Developments/Updates
Table 99. INRAD, Inc. (U.S.) Corporation Information
Table 100. INRAD, Inc. (U.S.) Description and Business Overview
Table 101. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 103. INRAD, Inc. (U.S.) Recent Developments/Updates
Table 104. Medtronic plc (Ireland) Corporation Information
Table 105. Medtronic plc (Ireland) Description and Business Overview
Table 106. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product
Table 108. Medtronic plc (Ireland) Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Stereotactic-guided Biopsy Instrument Distributors List
Table 112. Stereotactic-guided Biopsy Instrument Customers List
Table 113. Stereotactic-guided Biopsy Instrument Market Trends
Table 114. Stereotactic-guided Biopsy Instrument Market Drivers
Table 115. Stereotactic-guided Biopsy Instrument Market Challenges
Table 116. Stereotactic-guided Biopsy Instrument Market Restraints
Table 117. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Stereotactic-guided Biopsy Instrument
Figure 2. Global Stereotactic-guided Biopsy Instrument Market Share by Type in 2021 & 2028
Figure 3. Needle-based Biopsy Instruments Product Picture
Figure 4. Localization Wires Product Picture
Figure 5. Procedure Trays Product Picture
Figure 6. Others Product Picture
Figure 7. Global Stereotactic-guided Biopsy Instrument Market Share by Application in 2021 & 2028
Figure 8. Breast Biopsy
Figure 9. Lung Biopsy
Figure 10. Colorectal Biopsy
Figure 11. Prostate Biopsy
Figure 12. Others
Figure 13. Global Stereotactic-guided Biopsy Instrument Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Stereotactic-guided Biopsy Instrument Market Size (2017-2028) & (US$ Million)
Figure 15. Global Stereotactic-guided Biopsy Instrument Sales (2017-2028) & (K Units)
Figure 16. Stereotactic-guided Biopsy Instrument Sales Share by Manufacturers in 2021
Figure 17. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Stereotactic-guided Biopsy Instrument Players: Market Share by Revenue in 2021
Figure 19. Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2017-2022)
Figure 21. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region in 2021
Figure 22. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2017-2022)
Figure 23. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region in 2021
Figure 24. U.S. Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Taiwan Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Philippines Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Vietnam Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Mexico Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Brazil Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Argentina Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. UAE Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Stereotactic-guided Biopsy Instrument by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Stereotactic-guided Biopsy Instrument
Figure 50. Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument
Figure 51. Stereotactic-guided Biopsy Instrument Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs